Local view for "http://purl.org/linkedpolitics/eu/plenary/2008-10-22-Speech-3-042"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2008-10-22"^^xsd:date2
dcterms:Is Part Of	lp_eu:Variations to the terms of marketing authorisations for medicinal products - Counterfeiting of medicinal products (debate)2
dcterms:Language	"ro"^^xsd:language2
lpv:document identification number	"en.20081022.2.3-042"2
lpv:hasSubsequent	lp_eu:2008-10-22-Speech-3-0432
lpv:speaker	lp:Rareș-Lucian Niculescu2
lpv:spokenAs	member; Delegation for relations with the Maghreb countries and the Arab Maghreb Union (including Libya) (2008-02-18--2009-07-13)3 member; EPP-ED (2007-12-10--2009-07-13)3 unknown; Partidul Democrat-Liberal (2008-04-08--2009-07-13)3 substitute; Delegation for relations with the Gulf States, including Yemen (2007-12-18--2009-07-13)3 substitute; JURI (2007-12-12--2009-07-13)3 member; LIBE (2007-12-13--2009-07-13)3
lpv:translated text	"The European Union needs clear and stringent regulations with regard to the conditions for launching medicines on the market, and for all medicinal products in general too. I would like to illustrate the need for this by referring to a recent case which occurred in Romania. In September, a woman died following an operation during which unsterilised surgical thread imported from China was used. Other patients suffered complications which put their lives in danger. The Romanian Health Ministry’s inquiry committee acknowledged without a doubt that the surgical thread in question did not carry the CE quality mark. The law on assessing the products’ compliance clearly shows that the guilt lies mainly at the door of the relevant ministry, but clearer rules and greater transparency could have prevented this situation."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph